We’re with you
every day
Anovo’s patients are our first priority
We’ve built our unique care management model to ensure that you have constant and consistent access to the therapies you need and experts to help guide you through your therapeutic journey.
Meet some of our patients and hear their stories about how we help.
We understand the hurdles you face as a rare disease patient or caregiver
You’re one of an estimated 300 million people worldwide facing these challenges, but you have unique needs. There are so many rare diseases that medical expertise and therapeutic support for each is hard to find. That’s why we’ve dedicated ourselves to exclusively and comprehensively filling this gap.
99%
patient satisfaction ratings over 7 years.
97%
patient adherence through 90 days
"Every step of the way has been simple and easy to navigate thanks to the hard work and kindness of every employee I’ve spoken to. Thank you!"
"The staff at Anovo have exceeded my expectations. They go above and beyond for their clients. They have great customer service, and have always treated me with the utmost respect and kindness. Thank you!"
We tailor our care to each patient’s unique situation
Providing comprehensive care and support requires focused dedication and customization for every patient we serve.
With your personal Care Coordinator as the point person, all patient services are coordinated for you, including collaboration with our own, in-house reimbursement specialists and specialty pharmacy.
Our insurance experts make sure you get coverage fast and begin therapy quickly, without financial anxiety.
And because we also manage every step of the medication delivery chain – from the point of manufacture to your door – you never need to worry about running out of the medications you depend on.
When you have questions or concerns, or your situation changes, we encourage you call your Care Coordinator right away. That’s why we’re here.
Patient Resources
Patient Frequently Asked Questions
It starts with a conversation. Contact us today.

